israel
Written by
in
As the popularity of Ozempic, Victoza, Wegovy and other GLP-1 agonists have continued to increase, … More so have restrictions on insurance coverage for many of them. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty…